Perfusion imaging and recurrent cerebrovascular events in intracranial atherosclerotic disease or carotid occlusion
暂无分享,去创建一个
Sara K. Rostanski | K. Furie | M. Elkind | R. Marshall | M. Siket | M. Jayaraman | J. Willey | R. McTaggart | S. Prabhakaran | P. Khatri | S. Yaghi | Bradford B Thompson | Andrew D Chang | Morgan L Hemendinger | S. Cutting | Tina Burton | Brian C. Mac Grory | D. Sacchetti | Bradford B. Thompson | B. M. Mac Grory | Daniel C. Sacchetti | Tina M Burton
[1] S. Ansari,et al. Challenges in the Medical Management of Symptomatic Intracranial Stenosis in an Urban Setting , 2017, Stroke.
[2] M. Chimowitz,et al. Stroke Caused by Atherosclerosis of the Major Intracranial Arteries , 2017, Circulation research.
[3] Vertebrobasilar atherosclerotic disease: is it time to revisit angioplasty? , 2016, Journal of NeuroInterventional Surgery.
[4] Sara K. Rostanski,et al. Imaging Parameters and Recurrent Cerebrovascular Events in Patients With Minor Stroke or Transient Ischemic Attack. , 2016, JAMA neurology.
[5] K. Thulborn,et al. Effect of Hemodynamics on Stroke Risk in Symptomatic Atherosclerotic Vertebrobasilar Occlusive Disease. , 2016, JAMA neurology.
[6] J. Carroll,et al. Letter by Saver et al regarding article, "Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association". , 2015, Stroke.
[7] H. Kirshner,et al. Effect of a balloon-expandable intracranial stent vs medical therapy on risk of stroke in patients with symptomatic intracranial stenosis: the VISSIT randomized clinical trial. , 2015, JAMA.
[8] M. Krause,et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection. , 2015, The New England journal of medicine.
[9] C. Sudlow,et al. Pathogenic Ischemic Stroke Phenotypes in the NINDS-Stroke Genetics Network , 2014, Stroke.
[10] Z. Rumboldt,et al. Infarct Patterns, Collaterals and Likely Causative Mechanisms of Stroke in Symptomatic Intracranial Atherosclerosis , 2014, Cerebrovascular Diseases.
[11] Mark D. Johnson,et al. Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial , 2014, The Lancet.
[12] T. Turan,et al. Atherosclerotic intracranial arterial stenosis: risk factors, diagnosis, and treatment , 2013, The Lancet Neurology.
[13] A. Demchuk,et al. Perfusion MR Predicts Outcome in High-Risk Transient Ischemic Attack/Minor Stroke: A Derivation–Validation Study , 2013, Stroke.
[14] Manabu Inoue,et al. MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study , 2012, The Lancet Neurology.
[15] S. Dey. Stenting versus Aggressive Medical Therapy for Intracranial Arterial Stenosis , 2012 .
[16] T. Turan,et al. Collaterals dramatically alter stroke risk in intracranial atherosclerosis , 2011, Annals of neurology.
[17] Geoffrey A. Donnan,et al. RAPID Automated Patient Selection for Reperfusion Therapy: A Pooled Analysis of the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET) and the Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution (DEFUSE) Study , 2011, Stroke.
[18] K. Tan,et al. Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial , 2010, The Lancet Neurology.
[19] M. Marks,et al. Angioplasty for Symptomatic Intracranial Stenosis: Clinical Outcome , 2006, Stroke.
[20] H. A. Smith,et al. A standardized method for measuring intracranial arterial stenosis. , 2000, AJNR. American journal of neuroradiology.